Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

429087

	registered interest
	date	18/11/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Department of Health: Lobbying
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will assess the extent to which grants made by his Department to third parties are used for activities designed to influence his Department, other departments or Parliament.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	16779
	answer	answer is ministerial correction date of answer 23/11/2015 answer text <p>Funding applications from voluntary sector organisations are assessed against a number of criteria, but Departmental policy clearly states that grants will not be awarded if there is any indication within the application that some or all of any funding awarded will be used to support political activities, including political lobbying activity.</p><br /><p>It remains an important objective of the Department’s partnership with the voluntary, community and social enterprise sector that they contribute their voice and expertise to national policy making and implementation, and grant awards can support this objective.</p><br /><p>However, analysis of each individual grant awarded by the Department to ascertain the impact of this objective would be at disproportionate cost.</p><br /> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 16835 question first answered 23/11/2015 15:53:41 answering member 1201 label Biography information for Alistair Burt
	tabling member	1447 label Biography information for Andrew Rosindell

423894

	registered interest
	date	26/10/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	MRSA
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will make a comparative assessment of the number of recorded MRSA infections in (a) Havering and (b) other districts in (i) the present and (ii) the last three years; and if he will make a statement.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	13412
	answer	answer is ministerial correction date of answer 03/11/2015 answer text <p>Public Health England (PHE) is unable to provide the number of recorded Methicillin Resistant <em>Staphylococcus Aureus</em> (MRSA) infections by borough/district.</p><br /><p>PHE is able to provide this information by clinical commissioning groups (CCGs) and acute trusts.</p><br /><p>Table 1 details counts/rates of total MRSA bacteraemia reported by Havering, Barking and Redbridge University hospitals trust and Table 2 lists counts/rates of MRSA bacteraemia attributed to Havering CCG over the last three financial years.</p><br /><p>It is important to note that MRSA bacteraemia cases are reported by the acute trust whose laboratory processes the specimen and that this may not always reflect where the bacteraemia was acquired. Counts/rates for total MRSA bacteraemia reported in other CCGs and acute trusts in England is attached and can be found on the gov.uk website:</p><br /><p><a href="https://www.gov.uk/government/statistics/mrsa-bacteraemia-annual-data" target="_blank">https://www.gov.uk/government/statistics/mrsa-bacteraemia-annual-data</a></p><br /><p>PHE is working, with partner organisations, to address antimicrobial resistance through the implementation of the ‘UK Five Year Antimicrobial Resistance Strategy’<sup>1</sup>.</p><br /><p><strong><br> </strong></p><br /> <br /> <br /><p>Table 1: Financial year counts and rates of total MRSA bacteraemia reported by Havering, Barking &amp; Redbridge University hospitals (FY 2012/13 to FY 2014/15)</p><br /><table><tbody><tr><td><p><br></p></td><td colspan="2"><p>FY 2012/13</p></td><td colspan="2"><p>FY 2013/14</p></td><td colspan="2"><p>FY 2014/15</p></td></tr><tr><td><p>Trust Code</p></td><td><p>Trust Name</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td><td><p>MRSA bacteraemia reports</p></td><td><p>MRSA bacteraemia rate per 100,000 bed days</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p><br></p></td><td><p>England Total</p></td><td><p>924</p></td><td><p>2.7</p></td><td><p>862</p></td><td><p>2.5</p></td><td><p>801</p></td><td><p>2.3</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>RF4</p></td><td><p>Barking, Havering and Redbridge University Hospitals</p></td><td><p>17</p></td><td><p>4.7</p></td><td><p>10</p></td><td><p>2.9</p></td><td><p>13</p></td><td><p>3.7</p></td></tr></tbody></table><br /> <br /><p><em>Source:</em> PHE July 2015 annual publication of surveillance data</p><br /><p><em>Notes:</em></p><p>Bed days were calculated using KH03 data for the stated period. The average daily bed occupancy for the Trust quoted has been multiplied by the number of days in the time period. Rate per 100,000 bed days is calculated as follows<strong>:</strong></p><p>Calculation of rate (per 100,000 bed days) = [Number of MRSA bacteraemia reports from the trust for the time period divided by Average daily bed occupancy multiplied by Number of days in the time period] multiplied by 100,000</p><br /> <br /><p>NB: Included KH03 data are as of April 2015. KH03 data for January to March 2015 were not available at this time. Data for the same quarter last year (January to March 2014) has been used in FY 2014/15 bed day calculation.</p><br /> <br /><p>Table 2: Financial year counts and rates of MRSA bacteraemia attributed to Havering CCG (FY 2012/13 to FY 2014/15)</p><br /><table><tbody><tr><td><p><br></p></td><td><p><br></p></td><td colspan="2"><p>FY 2012/13</p></td><td colspan="2"><p>FY 2013/14</p></td><td colspan="2"><p>FY 2014/15</p></td></tr><tr><td><p>CCG Code</p></td><td><p>CCG Name</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td><td><p>Total attributed MRSA bacteraemia specimens</p></td><td><p>MRSA bacteraemia rate per 100,000 population</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p><br></p></td><td><p>England Total</p></td><td><p>924</p></td><td><p>1.7</p></td><td><p>862</p></td><td><p>1.6</p></td><td><p>801</p></td><td><p>1.5</p></td></tr><tr><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td><td><p><br></p></td></tr><tr><td><p>08F</p></td><td><p>Havering</p></td><td><p>9</p></td><td><p>3.8</p></td><td><p>6</p></td><td><p>2.5</p></td><td><p>6</p></td><td><p>2.5</p></td></tr></tbody></table><br /> <br /><p>Source: PHE July 2015 annual publication of surveillance data</p><br /><p><em>Notes:</em> CCG Populations are based upon Office for National Statistics (ONS) Mid-Year Population Estimates (2011 Census based). The relevant rate per 100,000 population was calculated as follows:</p><br /><p>Calculation of rate (per 100,000 bed days) = [Number of MRSA bacteraemia reports from that CCG for the given time period divided by CCG level population estimate] multiplied by 100,000</p><br /><p>NB: Included population data are as of April 2015. 2014 population estimates were not available at this time. 2013 population estimate data has been used as a proxy for the FY 2014/15 population.</p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 03/11/2015 17:47:39 answering member 3988 label Biography information for Ben Gummer attachment 1 file name Copy of MRSA_annual_data_FY_2014_2015.xls title MRSA data 2014-15
	tabling member	1447 label Biography information for Andrew Rosindell

435888

	registered interest
	date	07/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Doctors: English Language
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department is taking to ensure that doctors from the EU working in the NHS have adequate English skills to practice.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	18964
	answer	answer is ministerial correction date of answer 10/12/2015 answer text <p>In 2014 powers were given to the General Medical Council to enable them to carry out proportionate language checks on doctors from the European Union who wish to practise in the United Kingdom. This is a major step forward for quality of care and patient safety by ensuring that only doctors with adequate English language skills are able to practise in the UK.</p><br /><p>Local checks are also carried out by individual employers as part of their recruitment processes.</p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 10/12/2015 14:20:13 answering member 3988 label Biography information for Ben Gummer
	tabling member	1447 label Biography information for Andrew Rosindell

435889

	registered interest
	date	07/12/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Doctors: Migrant Workers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the implementation of European Professional Cards for doctors does not inhibit his Department's ability to perform background checks on doctors from European countries and to ensure that they meet the medical qualification standards required by the NHS.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	18965
	answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The European Professional Card (EPC) will not be introduced for doctors until 2018 at the earliest. The European Commission will review the effectiveness of the EPC process for the first wave of professions, which includes nurses, pharmacists and physiotherapists, before any decision is taken to extend the EPC to other professions.</p><br /><p>In the United Kingdom, independent health regulators are responsible for performing checks on health professionals from European countries to ensure that they meet agreed standards of fitness to practise. For doctors, this role is undertaken by the General Medical Council.</p><br /><p>Although under the EPC system the responsibility for carrying out initial background checks will transfer to the home regulator of the professional, UK regulators will continue to be able to carry out registration checks, and can require additional information if there are any justifiable doubts about a registrant’s application or fitness to practise.</p><br /><p>The UK Government has negotiated new safeguards to ensure that the high standards we expect from staff in this country are met by those from elsewhere in Europe who come to work here. These include:</p><br /><p>- the introduction of an EU-wide alert mechanism which regulators will use to inform other countries of professionals who have been restricted from practising; and</p><p>- applying language controls for healthcare professionals from the EU so that regulators are able to ensure that professionals have the necessary knowledge of English before they are able to work in the UK.</p> answering member constituency Ipswich answering member printed Ben Gummer question first answered 15/12/2015 17:30:42 answering member 3988 label Biography information for Ben Gummer
	tabling member	1447 label Biography information for Andrew Rosindell

114823

	registered interest
	date	05/11/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Translation Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, if he will confirm how much his Department has spent on translation services since January 2011.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	213626
	answer	answer is ministerial correction date of answer 17/11/2014 answer text <p>Departmental translation and interpreter spend from January 2011 is provided in the following table.</p><p> </p><table><tbody><tr><td><p>Departmental Spend (excluding VAT)</p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>Category</p></td><td><p>Year</p></td><td><p>Total</p></td></tr><tr><td rowspan="4"><p>Interpretation and Translation costs</p></td><td><p>2011</p></td><td><p>£3,653</p></td></tr><tr><td><p>2012</p></td><td><p>£5,831</p></td></tr><tr><td><p>2013</p></td><td><p>£4,067</p></td></tr><tr><td><p>2014</p></td><td><p>£31,951</p></td></tr><tr><td><p>Interpretation and Translation Total</p></td><td><p> </p></td><td><p>£ 45,502</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures are taken from the Department’s Business Management System where they are jointly categorised as translation and interpreter services. Information is based on all calendar years from January 2011 and up to 30 September 2014.</p><p> </p><p>The significant increase in spend in 2014 can be primarily attributed to the translator and associated costs for the Global Action Against Dementia Summit.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 17/11/2014 14:49:11 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1447 label Biography information for Andrew Rosindell

64771

	registered interest
	date	30/06/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Parkinson's Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what direct funding his Department has made available for research into Parkinson's disease.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	203182
	answer	answer is ministerial correction date of answer 07/07/2014 answer text <p>The Department's National Institute for Health Research (NIHR) spent £4.0 million in 2013-14 on Parkinson's disease research through research programmes, research centres and units, and research fellowships.</p><p><strong> </strong></p><p>The usual practice of the NIHR is not to ring-fence funds for expenditure on particular topics: research proposals in all areas compete for the funding available. The NIHR welcomes funding applications for research into any aspect of human health, including Parkinson's disease. These applications are subject to peer review and judged in open competition, with awards being made on the basis of the importance of the topic to patients and the National Health Service, value for money and scientific quality.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 07/07/2014 15:58:58 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1447 label Biography information for Andrew Rosindell

90162

	registered interest
	date	01/09/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Plastic Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what criteria are employed by the NHS in determining whether plastic surgery will be funded by the NHS.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	207696
	answer	answer is ministerial correction date of answer 08/09/2014 answer text <p> </p><p>Plastic surgery is a procedure used for repairing and reconstructing missing or damaged tissue and skin, usually due to surgery, illness, injury or an abnormality present from birth. Plastic surgery for these purposes is usually carried out free of charge on the National Health Service and is commissioned locally by clinical commissioning groups. The NHS Choices website provides advice on access to plastic surgery and states that most patients are referred to NHS plastic surgeons by their general practitioner or specialist consultant.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 08/09/2014 15:28:19 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1447 label Biography information for Andrew Rosindell

93239

	registered interest
	date	14/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: Temporary Employment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much the NHS has spent on agency (a) nurses, (b) midwives and (c) physiotherapists in 2014 to date.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	210351
	answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>The Department does not collect information on how much the National Health Service has spent on specific staff groups such as agency nurses, midwives and physiotherapists. In the Department of Health Annual Report and Accounts, we publish, for the financial year, how much each type of NHS organisation has spent on temporary and agency staff.</p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 21/10/2014 15:06:51 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1447 label Biography information for Andrew Rosindell

93250

	registered interest
	date	14/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Hospitals: Food
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps his Department takes to monitor the quality of food supplied at hospitals.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	210354
	answer	answer is ministerial correction date of answer 21/10/2014 answer text <p>Hospitals have a responsibility to provide high quality food and drink that meets each patient’s needs. The Department introduced Patient-Led Assessments of the Care Environment (PLACE) in April 2013 to assess the quality of the patient environment, including hospital food. PLACE is a voluntary process which takes place annually, and applies to hospitals, hospices and day treatment centres providing National Health Service funded care. PLACE is now the responsibility of NHS England.</p><p> </p><p> </p><p> </p><p>The results of the 2014 PLACE were published on the Health and Social Care Information Centre’s website on 27 August 2014. This data is available at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://hefs.hscic.gov.uk/PLACE.asp" target="_blank">http://hefs.hscic.gov.uk/PLACE.asp</a></p><p> </p><p> </p><p> </p><p>Selected hospital food data from the latest PLACE results has also been published on the NHS Choices website. Patients are able to see how hospital food is rated for quality and choice at their local hospital. This data is available at the following link:</p><p> </p><p> </p><p> </p><p><a href="http://www.nhs.uk/NHSEngland/AboutNHSservices/NHShospitals/Pages/hospital-food-standards.aspx" target="_blank">http://www.nhs.uk/NHSEngland/AboutNHSservices/NHShospitals/Pages/hospital-food-standards.aspx</a></p><p> </p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 21/10/2014 15:04:07 answering member 3932 label Biography information for Dr Dan Poulter
	tabling member	1447 label Biography information for Andrew Rosindell

101878

	registered interest
	date	30/10/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Abortion
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, how much has been spent on RU486 in each year since January 2011.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	212552
	answer	answer is ministerial correction date of answer 06/11/2014 answer text <p>Information on the net ingredient cost of mifepristone (RU486) used in National Health Service secondary care in England is shown in the table. This may include use in private wards in NHS hospitals and excludes use in military or private hospitals. Mifepristone is not used in primary care.</p><p> </p><p> </p><p> </p><table><tbody><tr><td colspan="2"><p>Net ingredient cost of mifepristone in secondary care, England</p></td></tr><tr><td><p> </p><p>Year</p></td><td><p>Net ingredient cost <br> £000s</p></td></tr><tr><td><p>2013</p></td><td><p>1,107.8</p></td></tr><tr><td><p>2012</p></td><td><p>1,113.6</p></td></tr><tr><td><p>2011</p></td><td><p>1,153.4</p></td></tr></tbody></table><p> </p><p><em>Source:</em> Hospital Pharmacy Audit Index (HPAI) provided by IMS Health</p><p> </p><p><strong> </strong></p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 06/11/2014 13:27:01 answering member 4020 label Biography information for George Freeman
	tabling member	1447 label Biography information for Andrew Rosindell